Therapeutic vaccination against chronic hepatitis C virus infection.
about
The advances in research on the pharmacological effects of Fructus Ligustri LucidiBest strategies for global HCV eradication.Cell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors.Prediction of T-cell epitopes of hepatitis C virus genotype 5aThe roles of endoplasmic reticulum overload response induced by HCV and NS4B protein in human hepatocyte viability and virus replication.Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system.High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance.Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses.Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.Hepatitis C virus vaccines in the era of new direct-acting antivirals.TLR9-Mediated Conditioning of Liver Environment Is Essential for Successful Intrahepatic Immunotherapy and Effective Memory Recall.Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial.
P2860
Q27002425-FB82B404-9D8D-4651-B87A-75FF8FFFD3E3Q27693824-C319EF8B-4637-4E94-8BE0-C245196D06E5Q30541731-28BB9BA5-9552-411A-9E7A-3E46CBCE7586Q34896702-55822BEB-7750-4B69-943E-87F2AB993516Q35393817-1F63A610-7131-4EEF-84B9-2D2D5848B9AFQ35723422-74C8B1A4-1A49-4B6C-8F59-4C715B6C69B5Q36978998-A9521E28-6C0A-4251-B50A-C764569749F0Q37383212-2AE92D77-6103-4AB2-AB82-48D428617F6CQ37696017-6FD05C6D-B8A9-41D2-89CF-4DA1DA290E7CQ38096490-2B7C4715-F834-4311-904E-54D077201BFEQ38410753-6245E48A-9E20-453F-9CD1-E62FFC107A6EQ40119511-0F9FDBF9-E966-49E2-BAC5-7B95D486E8E6Q41654330-7CABDAAE-44F4-469E-B3B5-C8BE42F58B53
P2860
Therapeutic vaccination against chronic hepatitis C virus infection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic vaccination against chronic hepatitis C virus infection.
@en
type
label
Therapeutic vaccination against chronic hepatitis C virus infection.
@en
prefLabel
Therapeutic vaccination against chronic hepatitis C virus infection.
@en
P1433
P1476
Therapeutic vaccination against chronic hepatitis C virus infection.
@en
P2093
Hans W Nijman
Peng Peng Ip
P356
10.1016/J.ANTIVIRAL.2012.07.006
P577
2012-07-25T00:00:00Z